Nvov Nordisk stock rose after a study showed Ozempic reduced the risk of heart attack, stroke and death by 23% compared with ...

Pharmaceutical giant Eli Lilly expanded its Virginia facility investment plans to $5 billion from original $2.1 billion amid ...

Eli Lilly and Company LLY announced plans to spend $5 billion to build a massive new manufacturing facility in Virginia as ...

AbbVie ABBV has gained 22.5% so far this year against a decrease of 0.1% for the industry. The stock has also outperformed ...

Eli Lilly and Company has recently surpassed a significant technical benchmark, reclaiming the 50-day moving average, ...

Eli Lilly shares move past the 50-day SMA as weight-loss drug data, rising sales and pipeline momentum fuel optimism.

Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock ...

Eli Lilly and Company recently saw its stock price climb +1.51%, reaching $738.17, and surpassing the S&P 500's modest gain ...

Eli Lilly (LLY) stock in focus as a federal appeals court upholds a lower court ruling which ordered the company to pay ...

Big Pharma faces tariff risks, patent cliffs, and regulatory pressure, but innovation and strong pipelines keep Eli Lilly, ...

Eli Lilly LLY announced that the phase III BRUIN CLL-313 study, evaluating its BTK inhibitor Jaypirca (pirtobrutinib) versus ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.